Attenuation of everolimus-induced cytotoxicity by a protective autophagic pathway involving ERK activation in renal cell carcinoma cells
Yizhou Zeng, Xiaofang Tian, Quan Wang, Weiyang He, Jing Fan, Xin Gou Department of Urinary Surgery, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China Aim: The mammalian target of rapamycin (mTOR) pathway is a critical target for cancer treatment and th...
Saved in:
Main Authors: | Zeng YZ (Author), Tian XF (Author), Wang Q (Author), He WY (Author), Fan J (Author), Gou X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ERK Inhibitor Enhances Everolimus Efficacy through the Attenuation of dNTP Pools in Renal Cell Carcinoma
by: Yun Zou, et al.
Published: (2019) -
Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway
by: Wang Y, et al.
Published: (2019) -
Role of everolimus in the treatment of renal cell carcinoma
by: Saby George, et al.
Published: (2009) -
Activation of ERK-p53 and ERK-Mediated Phosphorylation of Bcl-2 Are Involved in Autophagic Cell Death Induced by the c-Met Inhibitor SU11274 in Human Lung Cancer A549 Cells
by: Ying Liu, et al.
Published: (2012) -
Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
by: Sabrina Rossetti, et al.
Published: (2017)